Tooth-Related sinusitis study halted early – results uncertain
NCT ID NCT04085536
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at whether treating the dental cause of chronic maxillary sinusitis with dental procedures and medication could resolve symptoms. Only 16 patients were enrolled before the study was terminated. The main goal was to see if symptoms disappeared and pus cleared from the nasal passage. Because the trial stopped early, the findings are limited.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- dental and medical treatment
- What this could lead to
- If successful, this approach could offer a non-surgical option for managing chronic sinusitis caused by dental issues.
- What could go wrong
- The trial was terminated early with very few participants, so results are limited and may not be reliable. It is unclear if the treatment works better than standard care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
16 people
The number who actually took part.
- Started
-
Oct 2019
- Finished
-
Feb 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Age ≥ 18 years old 2. Signed Informed Consent 3. Patient with chronic maxillary sinusitis diagnosed by examination of the patient and ENT examination by naso-fibroscopy 4. Sinus imaging to confirm the diagnosis (facial mass scanner or cone beam CT) 5. Affiliated or beneficiary of a social security scheme Exclusion Criteria: 1. Fungal bullet sinusitis 2. Naso-sinus polyposis 3. atelectasic sinusitis 4. Systemic damage that may affect the maxillary sinuses (muciviscidosis, primary ciliary dyskinesia, vasculitis, granulomatosis, history of radiotherapy of the facial mass, pregnancy) 5. Long-term immunosuppressive treatment (chemo, anti-rejection) 6. Rhinosinusian tumor process 7. Fronto-ethmoidomaxillary sinusitis with risk of orbital or meningeal damage in the short to medium term. 8. Refusal of consent 9. Simultaneous participation in another intervention research 10. Patient under guardianship, curatorship or justice protection
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Chronic maxillary sinusitis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU Bicêtre
Le Kremlin-Bicêtre, 94270, France
-
Centre Hopitalier Intercommunal Robert Ballanger
Aulnay-sous-Bois, 93600, France
-
Centre Hospitalier Intercommunal de Créteil
Créteil, 94000, France
-
Groupe Hospitalier Intercommunal Le Raincy-Montfermeil
Montfermeil, 93370, France
-
Hôpital Henri Mondor
Créteil, 94010, France